Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Polio Virus | Research article

An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018

Authors: Brook Tesfaye, Alieu Sowe, Ngina Kisangau, John Ogange, Stephen Ntoburi, Irene Nekar, Charles Muitherero, Yaya Camara, Carolyne Gathenji, Daniel Langat, Kibet Sergon, Hilary Limo, Rosemary Nzunza, Shem Kiptoon, David Kareko, Iheoma Onuekwusi

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

The poliovirus has been targeted for eradication since 1988. Kenya reported its last case of indigenous Wild Poliovirus (WPV) in 1984 but suffered from an outbreak of circulating Vaccine-derived Poliovirus type 2 (cVDPV2) in 2018. We aimed to describe Kenya’s polio surveillance performance 2016–2018 using WHO recommended polio surveillance standards.

Methods

Retrospective secondary data analysis was conducted using Kenyan AFP surveillance case-based database from 2016 to 2018. Analyses were carried out using Epi-Info statistical software (version 7) and mapping was done using Quantum Geographic Information System (GIS) (version 3.4.1).

Results

Kenya reported 1706 cases of AFP from 2016 to 2018. None of the cases were confirmed as poliomyelitis. However, 23 (1.35%) were classified as polio compatible. Children under 5 years accounted for 1085 (63.6%) cases, 937 (55.0%) cases were boys, and 1503 (88.1%) cases had received three or more doses of Oral Polio Vaccine (OPV). AFP detection rate substantially increased over the years; however, the prolonged health workers strike in 2017 negatively affected key surveillance activities. The mean Non-Polio (NP-AFP) rate during the study period was 2.87/ 100,000 children under 15 years, and two adequate specimens were collected for 1512 (88.6%) AFP cases. Cumulatively, 31 (66.0%) counties surpassed target for both WHO recommended AFP quality indicators.

Conclusions

The performance of Kenya’s AFP surveillance system surpassed the minimum WHO recommended targets for both non-polio AFP rate and stool adequacy during the period studied. In order to strengthen the country’s polio free status, health worker’s awareness on AFP surveillance and active case search should be strengthened in least performing counties to improve case detection. Similar analyses should be done at the sub-county level to uncover underperformance that might have been hidden by county level analysis.
Literature
1.
go back to reference Organization WH. WHO-recommended standards for surveillance of selected vaccine preventable diseases. Geneva: World Health Organization; 1999. Organization WH. WHO-recommended standards for surveillance of selected vaccine preventable diseases. Geneva: World Health Organization; 1999.
2.
go back to reference Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance systems to track progress toward polio eradication—worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep. 2017;66(13):359.PubMedPubMedCentral Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance systems to track progress toward polio eradication—worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep. 2017;66(13):359.PubMedPubMedCentral
3.
go back to reference Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison’s principles of internal medicine. New York City: McGraw-Hill Professional Publishing; 2018. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison’s principles of internal medicine. New York City: McGraw-Hill Professional Publishing; 2018.
4.
go back to reference Sevencan F, Ertem MA, Öner H, Aras-Kılınç E, Köse OÖ, Demircioğlu S, et al. Acute flaccid paralysis surveillance in Southeastern Turkey, 1999–2010. Turk J Pediatr. 2013;55(3):283–91.PubMed Sevencan F, Ertem MA, Öner H, Aras-Kılınç E, Köse OÖ, Demircioğlu S, et al. Acute flaccid paralysis surveillance in Southeastern Turkey, 1999–2010. Turk J Pediatr. 2013;55(3):283–91.PubMed
5.
go back to reference Ryan KJ, Ray CG. Medical microbiology, vol. 4. New York: McGraw Hill; 2004. p. 370. Ryan KJ, Ray CG. Medical microbiology, vol. 4. New York: McGraw Hill; 2004. p. 370.
6.
go back to reference Saleh J-EA, Vaz RG, Braka F, Abdelrahim K, Ningi AI. A critical look at 2015 acute flaccid paralysis (AFP) surveillance core indicators of Bauchi state, Nigeria. Sci J Public Health. 2016;4(4):326–9. Saleh J-EA, Vaz RG, Braka F, Abdelrahim K, Ningi AI. A critical look at 2015 acute flaccid paralysis (AFP) surveillance core indicators of Bauchi state, Nigeria. Sci J Public Health. 2016;4(4):326–9.
7.
go back to reference Lam R, Tsang T, Chan K, Lau Y, Lim W, Lam T, et al. Surveillance of acute flaccid paralysis in Hong Kong: 1997 to 2002. Hong Kong Med J. 2005;11(3):164–73.PubMed Lam R, Tsang T, Chan K, Lau Y, Lim W, Lam T, et al. Surveillance of acute flaccid paralysis in Hong Kong: 1997 to 2002. Hong Kong Med J. 2005;11(3):164–73.PubMed
8.
go back to reference Davarpanah M, Bakhtiari H, Mehrbani D, KHADEM AF. A 12-years surveillance of poliomyelitis and acute flaccid paralysis in Fars Province, Southern Iran; 2008. Davarpanah M, Bakhtiari H, Mehrbani D, KHADEM AF. A 12-years surveillance of poliomyelitis and acute flaccid paralysis in Fars Province, Southern Iran; 2008.
9.
go back to reference Frauenthal HW, Manning JVV. A manual of infantile paralysis: with modern methods of treatment, including reports based on the treatment of three thousand cases. Philadelphia: FA Davis Company; 1914. Frauenthal HW, Manning JVV. A manual of infantile paralysis: with modern methods of treatment, including reports based on the treatment of three thousand cases. Philadelphia: FA Davis Company; 1914.
10.
go back to reference Davis F. Passage through crisis: polio victims and their families. Abingdon: Routledge; 2017. Davis F. Passage through crisis: polio victims and their families. Abingdon: Routledge; 2017.
11.
go back to reference Halstead LS, Rossi CD. New problems in old polio patients: results of a survey of 539 polio survivors. Orthopedics. 1985;8(7):845–50.PubMed Halstead LS, Rossi CD. New problems in old polio patients: results of a survey of 539 polio survivors. Orthopedics. 1985;8(7):845–50.PubMed
12.
go back to reference Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635.PubMed Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635.PubMed
13.
go back to reference Alleman MM, Meyer SA, Mulumba A, Nyembwe M, Riziki Y, Mbule A, et al. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010–2012. J Infect Dis. 2014;210(suppl_1):S50–61.PubMed Alleman MM, Meyer SA, Mulumba A, Nyembwe M, Riziki Y, Mbule A, et al. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010–2012. J Infect Dis. 2014;210(suppl_1):S50–61.PubMed
14.
go back to reference Tegegne SG, MKanda P, Yehualashet YG, Erbeto TB, Touray K, Nsubuga P, et al. Implementation of a systematic accountability framework in 2014 to improve the performance of the Nigerian Polio Program. J Infect Dis. 2016;213(suppl_3):S96–S100.PubMedPubMedCentral Tegegne SG, MKanda P, Yehualashet YG, Erbeto TB, Touray K, Nsubuga P, et al. Implementation of a systematic accountability framework in 2014 to improve the performance of the Nigerian Polio Program. J Infect Dis. 2016;213(suppl_3):S96–S100.PubMedPubMedCentral
15.
go back to reference Gostin LO. International infectious disease law: revision of the World Health Organization’s International Health Regulations. JAMA. 2004;291(21):2623–7.PubMed Gostin LO. International infectious disease law: revision of the World Health Organization’s International Health Regulations. JAMA. 2004;291(21):2623–7.PubMed
16.
go back to reference Organization WH, Initiative GPE. Global polio eradication initiative: strategic plan 2010–2012. Geneva: World Health Organization; 2010. Organization WH, Initiative GPE. Global polio eradication initiative: strategic plan 2010–2012. Geneva: World Health Organization; 2010.
17.
go back to reference Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, et al. Progress toward polio eradication—worldwide, 2013–2014. MMWR Morb Mortal Wkly Rep. 2014;63(21):468.PubMedPubMedCentral Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, et al. Progress toward polio eradication—worldwide, 2013–2014. MMWR Morb Mortal Wkly Rep. 2014;63(21):468.PubMedPubMedCentral
18.
go back to reference Initiative GPE. Global polio surveillance action plan, 2018–2020. Geneva: Global Polio Eradication Initiative; 2019. Initiative GPE. Global polio surveillance action plan, 2018–2020. Geneva: Global Polio Eradication Initiative; 2019.
19.
go back to reference Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, et al. Progress toward polio eradication—worldwide, January 2017–march 2019. Morb Mortal Wkly Rep. 2019;68(20):458. Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, et al. Progress toward polio eradication—worldwide, January 2017–march 2019. Morb Mortal Wkly Rep. 2019;68(20):458.
21.
go back to reference Hornsby C. Kenya: a history since independence. London: IB Tauris; 2013. Hornsby C. Kenya: a history since independence. London: IB Tauris; 2013.
22.
go back to reference Ertem M, Sarac A, Tumay S. Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health. 2000;114(4):286–90.PubMed Ertem M, Sarac A, Tumay S. Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health. 2000;114(4):286–90.PubMed
23.
go back to reference Organization WH. Guidelines on responding to the detection of wild poliovirus in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2007. Organization WH. Guidelines on responding to the detection of wild poliovirus in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2007.
24.
go back to reference Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009–2013. BMC Public Health. 2014;14(1):687.PubMedPubMedCentral Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009–2013. BMC Public Health. 2014;14(1):687.PubMedPubMedCentral
25.
go back to reference Arita I, Nakane M, Fenner F. Is polio eradication realistic? Science. 2006;312(5775):852–4.PubMed Arita I, Nakane M, Fenner F. Is polio eradication realistic? Science. 2006;312(5775):852–4.PubMed
26.
go back to reference Organization WH. Acute flaccid paralysis (AFP) surveillance: the surveillance strategy for poliomyelitis eradication. Wkly Epidemiol Rec. 1998;73(16):113–4. Organization WH. Acute flaccid paralysis (AFP) surveillance: the surveillance strategy for poliomyelitis eradication. Wkly Epidemiol Rec. 1998;73(16):113–4.
27.
go back to reference Kohler KA, Hlady WG, Banerjee K, Gupta D, Francis P, Durrani S, et al. Compatible poliomyelitis cases in India during 2000. Bull World Health Organ. 2003;81:2–9.PubMedPubMedCentral Kohler KA, Hlady WG, Banerjee K, Gupta D, Francis P, Durrani S, et al. Compatible poliomyelitis cases in India during 2000. Bull World Health Organ. 2003;81:2–9.PubMedPubMedCentral
28.
go back to reference Khuzwayo LS, Kuonza LR, Ngcobo NJ. Evaluating the acute flaccid paralysis surveillance system in South Africa, 2005–2009-an analysis of secondary data. Pan Afr Med J. 2013;14(1):86.PubMedPubMedCentral Khuzwayo LS, Kuonza LR, Ngcobo NJ. Evaluating the acute flaccid paralysis surveillance system in South Africa, 2005–2009-an analysis of secondary data. Pan Afr Med J. 2013;14(1):86.PubMedPubMedCentral
29.
go back to reference Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, et al. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal. 2013;33(4):664–79.PubMed Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, et al. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal. 2013;33(4):664–79.PubMed
30.
go back to reference Bassey BE, Gasasira A, Mitula P, Frankson UU, Adeniji JA. Surveillance of acute flaccid paralysis in Akwa Ibom State, Nigeria 2004-2009. Pan Afr Med J. 2011;9(1):32.PubMedPubMedCentral Bassey BE, Gasasira A, Mitula P, Frankson UU, Adeniji JA. Surveillance of acute flaccid paralysis in Akwa Ibom State, Nigeria 2004-2009. Pan Afr Med J. 2011;9(1):32.PubMedPubMedCentral
31.
go back to reference Hamisu AW, Johnson TM, Craig K, Mkanda P, Banda R, Tegegne SG, et al. Strategies for improving polio surveillance performance in the security-challenged Nigerian States of Adamawa, Borno, and Yobe during 2009–2014. J Infect Dis. 2016;213(suppl_3):S136–S9.PubMedPubMedCentral Hamisu AW, Johnson TM, Craig K, Mkanda P, Banda R, Tegegne SG, et al. Strategies for improving polio surveillance performance in the security-challenged Nigerian States of Adamawa, Borno, and Yobe during 2009–2014. J Infect Dis. 2016;213(suppl_3):S136–S9.PubMedPubMedCentral
32.
go back to reference D'Errico MM, Barbadoro P, Bacelli S, Esposto E, Moroni V, Scaccia F, et al. Surveillance of acute flaccid paralysis in the marches region (Italy): 1997–2007. BMC Infect Dis. 2008;8(1):135.PubMedPubMedCentral D'Errico MM, Barbadoro P, Bacelli S, Esposto E, Moroni V, Scaccia F, et al. Surveillance of acute flaccid paralysis in the marches region (Italy): 1997–2007. BMC Infect Dis. 2008;8(1):135.PubMedPubMedCentral
33.
go back to reference Tegegne AA, Fiona B, Shebeshi ME, Hailemariam FT, Aregay AK, Beyene B, et al. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005–2015: progress and challenges. Pan Afr Med J. 2017;27(Suppl 2):10.PubMedPubMedCentral Tegegne AA, Fiona B, Shebeshi ME, Hailemariam FT, Aregay AK, Beyene B, et al. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005–2015: progress and challenges. Pan Afr Med J. 2017;27(Suppl 2):10.PubMedPubMedCentral
34.
go back to reference Olivé J-M, Castillo C, Castro RG, de Quadros CA. Epidemiologic study of Guillain-Barré syndrome in children< 15 years of age in Latin America. J Infect Dis. 1997;175(Supplement_1):S160–S4.PubMed Olivé J-M, Castillo C, Castro RG, de Quadros CA. Epidemiologic study of Guillain-Barré syndrome in children< 15 years of age in Latin America. J Infect Dis. 1997;175(Supplement_1):S160–S4.PubMed
35.
go back to reference Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines. 2015;14(5):749–62.PubMed Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines. 2015;14(5):749–62.PubMed
36.
go back to reference Sabin A, Boulger L. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand. 1973;1(2):115–8. Sabin A, Boulger L. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand. 1973;1(2):115–8.
37.
go back to reference Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31(12):1560–8.PubMed Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31(12):1560–8.PubMed
38.
go back to reference Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, et al. Progress toward poliomyelitis eradication in Nigeria. J Infect Dis. 2014;210(suppl_1):S40–S9.PubMed Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, et al. Progress toward poliomyelitis eradication in Nigeria. J Infect Dis. 2014;210(suppl_1):S40–S9.PubMed
39.
go back to reference Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, et al. Recombinant vaccine–derived poliovirus in Madagascar. Emerg Infect Dis. 2003;9(7):885.PubMedPubMedCentral Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, et al. Recombinant vaccine–derived poliovirus in Madagascar. Emerg Infect Dis. 2003;9(7):885.PubMedPubMedCentral
40.
go back to reference Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib ZA, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356–9.PubMed Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib ZA, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356–9.PubMed
Metadata
Title
An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018
Authors
Brook Tesfaye
Alieu Sowe
Ngina Kisangau
John Ogange
Stephen Ntoburi
Irene Nekar
Charles Muitherero
Yaya Camara
Carolyne Gathenji
Daniel Langat
Kibet Sergon
Hilary Limo
Rosemary Nzunza
Shem Kiptoon
David Kareko
Iheoma Onuekwusi
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Polio Virus
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05319-6

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.